NP / PA
Martin, Amanda
Martin, Amanda was paid $189K by Medicaid between Jan 2018 and Dec 2020, across 16 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 52% of everything it billed.
33Billing provider infoMARTIN, AMANDA
TAZEWELL, TN 37879
TAZEWELL, TN 37879
33aNPI1952690588assigned 04/05/2011
33bProvider typeFamily Nurse Practitioner
28Total paid$189K
24GClaims10,159
24DCodes billed16
24AFirst – last monthJan 2018 – Dec 2020
Compared with peers
Next to other Family Nurse Practitioner providers in Tennessee
Rank by total paid#85 of 687
Median peer was paid$15K
This provider vs. median13×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,500 | $77K | |
| 2019 | 4,029 | $62K | |
| 2020 | 2,630 | $50K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 52% | 3,589 | 2,581 | $99K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 17% | 999 | 835 | $32K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 7.0% | 1,420 | 580 | $13K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 4.9% | 846 | 530 | $9K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 4.9% | 323 | 177 | $9K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3.7% | 398 | 214 | $7K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3.6% | 659 | 563 | $7K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.3% | 167 | 167 | $6K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.2% | 126 | 94 | $4K |
| 81001 | <1% | 492 | 387 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 151 | 83 | $184.17 |
| 36415 | Collection of venous blood by venipuncture | <1% | 66 | 59 | $130.41 |
4 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.